Value-based enabler Valendo Health launches with focus on endocrinology –
Summary
A new value-based care enabler focused on endocrinology has launched with a mission to shape the future of diabetes care.Valendo Health uses a phased approach to offer expertise, technology and data-rich tools to help independent physicians enhance clinical capacity, streamline operations and transition to value-based care.The company was built at New York City-based startup creator Redesign Health in 2023 and has raised $4 million in seed funding. Valendo gets its name from value and endocrinology, and also means worth in Portuguese.The startup has announced two initial provider partners: Cecelia Health, a virtual provider for chronic care management, and Advanced Metabolic Care + Research (AMCR), an endocrinology center in Southern California.Diabetes is one of the...